Alpine Global Management, LLC Heron Therapeutics, Inc. Transaction History

Alpine Global Management, LLC

  • $265 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Nov 21, 2023
BUY
$1.51 - $3.25 $22,897 - $49,283
15,164 New
15,164 $22,000
Q1 2023

May 15, 2023
SELL
$1.51 - $3.25 $27,371 - $58,912
-18,127 Reduced 54.45%
15,164 $23,000
Q4 2022

Feb 14, 2023
BUY
$2.25 - $4.67 $74,904 - $155,468
33,291 New
33,291 $83,000

Others Institutions Holding HRTX

# of Institutions
173
Shares Held
114M
Call Options Held
2M
Put Options Held
32.4K
View Full List

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $284M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email